The Ensign Group, Inc. (ENSG) Stock Analysis
Market Closed
Sector: Healthcare · Industry: Services-Skilled Nursing Care Facilities
AnalystsStrong Buy12 analystsWhat's happening with ENSG
Price History
5-Year Weekly Candlestick Chart
Profile
Strong financial health and growth.
How is each axis scored?
- Valuation50/100 · Moderate
- P/E vs own history (62th pct)5/25
- FCF yield (n/a)10/25
- P/S (1.9x)25/25
- EV/EBIT (n/a)10/25
- Growth85/100 · Strong
- Revenue CAGR (17.8%)20/25
- Net income CAGR (15.3%)20/25
- EPS CAGR 5Y (14.3%)20/25
- Fwd implied growth (32.1%)25/25
- Profitability65/100 · Moderate
- ROIC (20.0%)20/25
- ROE (15.4%)20/25
- Net margin (6.9%)13/25
- Operating margin (8.5%)12/25
- Financial Health86/100 · Strong
- Altman Z (2.83)18/25
- Current ratio (1.56)18/25
- Interest coverage (34.7x)25/25
- Net cash / debt (Net cash)25/25
- Quality65/100 · Moderate
- Piotroski F (5/9)15/25
- Beneish M (-2.58)25/25
- FCF conversion (n/a)0/25
- Margin stability (σ 2.1%)25/25
About The Ensign Group, Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Show more
Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
Headquarters: SAN JUAN CAPISTRANO, CA · Employees: 46,000 · Website ↗
Insider Transactions
Recent SEC Form 4 filings
- SellGift · filed 2026-08-13-2500 sh2026-08-11
- SellOpen market sale · filed 2026-07-29-200 sh2026-07-27
- SellOpen market sale · filed 2026-07-29-175 sh2026-07-27
- SellOpen market sale · filed 2026-07-22-392 sh2026-07-20
- SellOpen market sale · filed 2026-07-17-100 sh2026-07-16
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
50CP/E (TTM)28.9xC
Grade C: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 20.5x–39.5x · 62nd pct
P/FCF24.3xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield4.1%C
Grade C: LowTTM FCF / Market Cap
P/S (TTM)1.95xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 1.5x–2.6x · 67th pct
EV/EBITDA17.3xB
Grade B: FairEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales1.8xA
Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E21.9xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio4.34xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio1.80B
Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield0.15%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio4.2%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
65BROIC20.0%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE15.4%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA6.9%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin6.9%C
Grade C: AverageNet Income / Revenue
Operating Margin8.5%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin20.6%D
Grade D: LowGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
86AAltman Z-Score2.83C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.56xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.35xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage34.7xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.06xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Growth
85ARevenue CAGR17.8%A
Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR15.3%A
Grade A: HighCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)14.3%C
Grade C: OkCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth32.1%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)+4.7%C
Grade C: DilutiveShare count change over 5Y
SBC / Net Income14.2%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue1.0%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
65BPiotroski F-Score5/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.58A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability2.1%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.93xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Per Share, Balance Sheet, MarketHide additional metrics
Per Share
EPS (TTM)$6.10
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$9.85
Cash & short-term investments per share (Finnhub)
Book Value / Share$38.42
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.$595.17M
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity$2.37B
Shareholders' equity (book value)
Asset / Liability1.73xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$10.28B
Current Market Capitalization
Beta0.68B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Neutral
Current P/E of 28.9x sits at the 62nd percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 23, 2026
Key Insights: The Ensign Group, Inc. (ENSG)
Composite verdict for The Ensign Group, Inc.: Neutral. Piotroski F-Score of 5/9 indicates mixed fundamentals for The Ensign Group, Inc.. Altman Z-Score of 2.83 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out.
- Beneish M-Score of -2.58 suggests a low likelihood of earnings manipulation.
- Revenue has compounded at roughly 18% annually, with net income growing about 15% per year — a strong growth profile.
See how ENSG ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for ENSG in the last 30 days.
See ENSG move history →Frequently Asked Questions about ENSG
Is ENSG stock a buy right now?
PreMarketPrice's quantitative model rates The Ensign Group, Inc.'s financial health at 86/100 — Neutral. This is a data-driven snapshot of fundamentals, not investment advice.
Is ENSG stock overvalued?
The Ensign Group, Inc. trades at a trailing P/E of 28.9 and our valuation score rates it 50/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does The Ensign Group, Inc. report earnings?
No confirmed earnings date is currently scheduled for ENSG. The Earnings section lists recent reports and updates as dates are announced.
What sector does The Ensign Group, Inc. operate in?
The Ensign Group, Inc. operates in the Healthcare sector, within the Services-Skilled Nursing Care Facilities industry. The Related Stocks section lists sector peers for comparison.
What does The Ensign Group, Inc. do?
Ensign Group Inc provides post-acute healthcare services in the United States.
About The Ensign Group, Inc. (ENSG) Stock
The Ensign Group, Inc. (ENSG) is a US-listed stock operating in the Healthcare sector, specifically the Services-Skilled Nursing Care Facilities industry. Real-time pricing data for The Ensign Group, Inc. is available on this page with a market capitalization of $10.3 billion. The financial health score for ENSG is 86/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for ENSG stock.
ENSG Stock Analysis & Key Metrics
On PreMarketPrice, you can track The Ensign Group, Inc. (ENSG) across multiple dimensions:
- Pre-market price & movement: Real-time ENSG stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for ENSG with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for The Ensign Group, Inc. across multiple reporting periods.
- Financial health score: A composite score of 86/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for ENSG.
- Sector peers: Compare ENSG against 10 other healthcare stocks on key financial metrics.
Is ENSG a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate The Ensign Group, Inc. (ENSG) as an investment. The financial health score of 86/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.The Ensign Group, Inc. (ENSG) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.